Skip to content
Sementis
Main menu
  • Home
  • About Us
  • Company
    • Executive Team & Board
    • Scientific Advisory
    • Company Reporting
    • Company Presentations
  • Platform Technology
    • SCV Platform
    • Needle-free Vaccination
  • Pipeline Products
    • Peanut Allergy
    • Cat Allergy
    • Chikungunya
    • dual chikungunya Zika
  • Scientific Presentations
  • Publications
  • Announcements
    • Press Releases
    • Investor Updates
  • Useful links
  • Vaccines Work!
  • Contact Us

Prow etal (2018) A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. Nat Comms. DOI: 10.1038/s41467-018-03662-6. 

Abstract

Eldi etal (2017) Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology. Molecular Therapy; 25 (10): 2332-2344

Abstract

Liu etal (2017) Transient dominant host-range selection using Chinese hamster ovary cells to generate marker-free recombinant viral vectors from vaccinia virus. BioTechniques; 62 (4): 183–187

Abstract

Liu etal (2014) From Crescent to Mature Virion: Vaccinia Virus Assembly and Maturation. Viruses; 6(10): 3787-3808

Abstract

Miller etal (2012) Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy. Expert. Rev. Vaccines; 11 (12): 1471-1481

 Abstract

Footer
  • Linked in
  • Website Design by SNAP Hallam VIC